01950nam a22003857a 4500
220124s20202020 xxu||||| |||| 00| 0 eng d
0739-9529
001234 [pii]
10.1055/s-0040-1720950 [doi]
PMC7732557 [pmc]
Ovid MEDLINE(R)
33328700
Treatment Options for Early-Stage Hepatocellular Carcinoma. [Review]
Seminars in Interventional Radiology. 37(5):448-455, 2020 Dec.
SEMIN. INTERVENT. RADIOL.. 37(5):448-455, 2020 Dec.
Seminars in interventional radiology
2020
FY2021
2020 Dec
ppublish
2020-12-31
Patients with early stage hepatocellular carcinoma have good prognosis and are treated with curative intent. Although this cohort of patients is generally defined by limited tumor burden, good liver function, and preserved functional status, there remains utility in further stratification to optimize overall survival and limit post-operative morbidity and mortality. Transplant, resection, ablation, transarterial radioembolization, and transarterial chemoembolization, either as monotherapy or in combination, may play a crucial role in treating this cohort of patients depending on a multitude of factors. In this section, we review each treatment modality and provide general guidelines for patient selection. Copyright Thieme. All rights reserved.
English
IN PROCESS -- NOT YET INDEXED
MedStar Medical Group
MedStar Washington Hospital Center
Radiology
Journal Article
Review
Sivananthan, Gajan
Tabori, Nora E
Sivananthan G, Tabori NE
https://dx.doi.org/10.1055/s-0040-1720950
https://dx.doi.org/10.1055/s-0040-1720950
ART
Article
0
0
0
0
Article
authcat
authcat
2020-12-31
0
33328700
33328700
2020-12-31
2020-12-31
ART
5982
5982